Partner with Consilient Health

We provide entrepreneurial and commercial healthcare solutions in the UK. If you are looking for a potential business partner and require further information about launching products in the UK or indeed Europe or the Middle East please get in touch to discuss our capabilities.

Our focus

Innovative solutions for patient health

Consilient Health is a pharmaceutical company with a rich heritage of commercialising products in areas such as women’s health and endocrinology.

In all our planning the patient is very much at the centre. Considering both the healthcare professional’s needs as well as those of the patient’s is key to our commercial success.

Who Are We?

Established in 2005, Consilient’s success has been built on cultivating strong partnerships with customers to provide prescription healthcare products.

Our team has extensive experience working across a broad range of therapeutic areas.

Our current portfolio includes a wide range of products in two main therapeutic areas, women’s health and endocrinology. We choose products where there is clear differentiation and an unmet clinical need.

What Do We Do?


Obesity has more than doubled in incidence globally since 1980.1

One of our new therapies helps patients with obesity lose weight. Its mode of action offers an alternative to existing therapies currently on the market.

Find out more about our anti-obesity prescription medication.

Bone Health

Our Bone Health portfolio includes a growing number of vitamin D3 (colecalciferol) prescription medicines2.

We are proud to offer a broad range of doses and formulations which gives patients and healthcare professionals a choice of options to suit their needs and preferences.

Find out more about our  licensed prescription vitamin D3 and calcium medication.


We work with a broad range of pharmaceutical companies to develop and licence generic products for the UK market. For a list of generic product available in the UK please click below for more information.

Click here for the current list of our generic products

Women’s health

Our range of contraceptives has been designed to meet the differing needs of patients. With our patient-centric approach we were able to identify and implement an innovative approach in the complex contraceptive market.

We offer the broadest portfolio of oral contraceptives (OCs) in the UK and Ireland, and lead the market in this area. In fact, 1 in 32 women in the UK who use OC will be taking a Consilient Health pill.

To find out more about our oral contraceptive care medicines visit


Globally, an estimated 422 million adults were living with diabetes in 2014, compared to 108 million in 1980.3

We have a slow release treatment for type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control.

What Is Our Focus?

At Consilient Health, innovative solutions for patient health are our focus. We offer a wide range of prescription products in the UK, offering high quality significant savings for the NHS, complemented by comprehensive support programmes for both medical professionals and patients.


1. World Health Organization 2016

2. MAT May 2017 IMS data

3. Global report on diabetes, World Health Organisation, 7 April 2016.

Code No: UK/CH/0118/0119a
Date of preparation: January 2018